Legend Biotech Corporation
LEGN
शेयरों में रैंक
#4427
Legend Biotech Corporation, through its subsidiaries, operates as a... Legend Biotech Corporation, through its subsidiaries, operates as a biopharmaceutical company that discovers, develops, manufactures, and commercializes novel cell therapies for oncology and other indications in the United States, China, and Europe. Its lead product candidate is ciltacabtagene autoleucel, or cilta-cel, which is a chimeric antigen receptor (CAR-T) therapy for the treatment of multiple myeloma (MM). The company also has a portfolio of earlier-stage autologous CAR-T product candidates targeting various cancers, including acute lymphoblastic leukemia, gastric cancer, esophageal cancer, pancreatic cancer, colorectal cancer, small cell lung cancer, and non-small cell lung cancer. In addition, it develops allogeneic gamma delta CAR-T and allogeneic CAR-NK product candidates targeting B-cell maturation antigen (BCMA) for MM, which are in investigator-initiated Phase 1 clinical trials in China. The company has a collaboration and license agreement with Janssen Biotech, Inc. for the development and commercialization of cilta-cel, as well as a license agreement with Novartis Pharma AG for the development, manufacture, and commercialization of CAR-T cell therapies targeting delta-like ligand protein 3. Legend Biotech Corporation was founded in 2014 and is headquartered in Somerset, New Jersey.
शेयर मूल्य
$19.06
मार्केट कैप
$3.53B
बदलाव (1 दिन)
0.29%
बदलाव (1 वर्ष)
-41.98%
देश
US
व्यापार Legend Biotech Corporation (LEGN)
श्रेणी
Healthcare
Legend Biotech Corporation (LEGN) के लिए बकाया शेयरों की संख्या
June 2026 की स्थिति में बकाया शेयरों की संख्या: 187.00M
Legend Biotech Corporation की नवीनतम वित्तीय रिपोर्ट और शेयर मूल्य के अनुसार, कंपनी के वर्तमान बकाया शेयरों की संख्या 187.00M है। December 2023 के अंत में कंपनी के पास 88.04M बकाया शेयर थे। बकाया शेयरों की संख्या आमतौर पर शेयर स्प्लिट्स और शेयर बायबैक से प्रभावित होती है।
Legend Biotech Corporation (LEGN) के लिए 2017 से 2026 तक बकाया शेयरों का इतिहास
प्रत्येक वर्ष के अंत में बकाया शेयर
| वर्ष | बकाया शेयर | परिवर्तन |
|---|---|---|
| 2026 (TTM) | 187.00M | 104.54% |
| 2024 | 91.43M | 3.84% |
| 2023 | 88.04M | 10.71% |
| 2022 | 79.52M | 12.91% |
| 2021 | 70.43M | 19.21% |
| 2020 | 59.08M | -10.49% |
| 2019 | 66.00M | 32.01% |
| 2018 | 50.00M | -24.25% |
| 2017 | 66.00M | 0.00% |
समान कंपनियों या प्रतिस्पर्धियों के लिए बकाया शेयर
| कंपनी | बकाया शेयर | अंतर | देश |
|---|---|---|---|
| 253.90M | 35.78% |
US
|
|
| 396.00M | 111.76% |
US
|
|
| 478.91M | 156.10% |
AU
|
|
| 62.19M | -66.75% |
NL
|
|
| - | - |
CH
|
